Please follow the following steps to conduct the financial analysis of Please follow the following steps to conduct the financial analysis of Pharmamax:

Enter the attached financial statements into a New Excel and make sure that the numbers have been

entered correctly so that you may upload it after you have completed the entire assignment. $(5$

marks$)$

Write an introduction that gives a brief outline of the Palestinian pharmaceutical sector. Include

critical information regarding the industry's market size, competitive landscape, export$-$import

dynamics, and regulatory frameworks. $(5$ marks$)$

Construct a cash flow statement for Pharmamax using the attached financial statements. This needs

to be done using both the direct and indirect methods. $(14$ marks$)$

Analyse the Pharmamax attached financial statements, including the cash flow statement, using the

following tools:

a$)$ Financial ratios$($all the ratios covered in class$)$ of pharmamax and those of the Palestinian

pharmaceutical company of your choice. $(15$ marks$)$

b$)$ Vertical common$-$size analysis: to understand the relative proportions of account balances for

each of the available years $(2021-2022).$ Compare to those of the Palestinian pharmaceutical

company of your choice. $(10$ Marks$)$

c$)$ Horizontal analysis: to determine trends and patterns of growth over time for the Pharmamax

company and compare to the competitor $(10$ Marks$)$

d$)$ Dupont Analysis. $(8$ marks$)$

e$)$ Z$-$score. $(8$ marks$)$

Interpret the company's financial performance based on ratio analysis and clarify the company's

liquidity performance, operational activity, profitability, and debt in comparison with the

competitive company of your choice. $(10$ marks$)$

Given the financial statements, calculate the basic earnings per share and the dilutive earnings per

share for the year ended $2022.$ Accordingly, find the weighted average number of shares

outstanding, and thereafter, find the basic and dilutive EPS, given that the company also has a

dilutive security represented in $15,000$ preferred stocks that pay $40\%$ of the dividends reported in

the income statement and are convertible into two common stocks each. In addition to $$60,000$ of

$4\mathrm{.}5\%$ convertible bonds, there is a total of $12,000$ common shares. Consider the following

information: $(10$ marks$)$Pharmamax:

Enter the attached financial statements into a New Excel and make sure that the numbers have been

entered correctly so that you may upload it after you have completed the entire assignment. $(5$

marks$)$

Write an introduction that gives a brief outline of the Palestinian pharmaceutical sector. Include

critical information regarding the industry's market size, competitive landscape, export$-$import

dynamics, and regulatory frameworks. $(5$ marks$)$

Construct a cash flow statement for Pharmamax using the attached financial statements. This needs

to be done using both the direct and indirect methods. $(14$ marks$)$

Analyse the Pharmamax attached financial statements, including the cash flow statement, using the

following tools:

a$)$ Financial ratios$($all the ratios covered in class$)$ of pharmamax and those of the Palestinian

pharmaceutical company of your choice. $(15$ marks$)$

b$)$ Vertical common$-$size analysis: to understand the relative proportions of account balances for

each of the available years $(2021-2022).$ Compare to those of the Palestinian pharmaceutical

company of your choice. $(10$ Marks$)$

c$)$ Horizontal analysis: to determine trends and patterns of growth over time for the Pharmamax

company and compare to the competitor $(10$ Marks$)$

d$)$ Dupont Analysis. $(8$ marks$)$

e$)$ Z$-$score. $(8$ marks$)$

Interpret the company's financial performance based on ratio analysis and clarify the company's

liquidity performance, operational activity, profitability, and debt in comparison with the

competitive company of your choice. $(10$ marks$)$

Given the financial statements, calculate the basic earnings per share and the dilutive earnings per

share for the year ended $2022.$ Accordingly, find the weighted average number of shares

outstanding, and thereafter, find the basic and dilutive EPS, given that the company also has a

dilutive security represented in $15,000$ preferred stocks that pay $40\%$ of the dividends reported in

the income statement and are convertible into two common stocks each. In addition to $$60,000$ of

$4\mathrm{.}5\%$ convertible bonds, there is a total of $12,000$ common shares. Consider the following

information: $(10$ marks$)$